Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst

Why did the Federal Reserve cut interest rates? How will Nvidia's $5B Intel investment affect tech? What caused StubHub’s IPO stock decline? Why was Jimmy Kimmel’s show suspended? How did Fed’s rate cut impact cryptocurrencies? What’s driving Cracker Barrel’s falling sales? Why is Tesla redesigning its door handles?

Voyager Therapeutics Alzheimer's Portfolio And ALPL NeuroShuttle Underscore Platform Momentum: Analyst

benzinga.com/analyst-stock-ratings/analyst-color/25/09/47675859/voyager-therapeutics-alzheimers-portfolio-and-alpl-neuroshuttle-underscore-pl

Last week, HC Wainwright hosted Voyager Therapeutics, Inc.’s (NASDAQ:VYGR) management during HCW's Annual Global Investment Conference.
The management emphasized recent preclinical murine data from a head-to-head study showing that its alkaline phosphatase (ALPL) receptor-mediated…

This story appeared on benzinga.com, 2025-09-15 18:00:31.